Intentional Rechallenge and the Clinical Management of Drug-Related Problems

被引：0
|
作者：
Ronald Meyboom
机构：
[1] University of Utrecht,Division of Pharmacoepidemiology and Clinical Pharmacology
来源：
Drug Safety | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 165
页数：2
相关论文
共 50 条
  • [1] Intentional Rechallenge and the Clinical Management of Drug-Related Problems
    Meyboom, Ronald
    [J]. DRUG SAFETY, 2013, 36 (03) : 163 - 165
  • [2] DUTCH POLICY ON THE MANAGEMENT OF DRUG-RELATED PROBLEMS
    ENGELSMAN, EL
    [J]. BRITISH JOURNAL OF ADDICTION, 1989, 84 (02): : 211 - 218
  • [3] The impact of clinical pharmacists on drug-related problems and clinical outcomes
    Viktil, Kirsten K.
    Blix, Hege Salvesen
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 (03) : 275 - 280
  • [4] A COMMENTARY ON DUTCH POLICY ON THE MANAGEMENT OF DRUG-RELATED PROBLEMS
    BERRIDGE, V
    [J]. BRITISH JOURNAL OF ADDICTION, 1989, 84 (09): : 989 - 990
  • [5] From "drug-related problems" to "negative clinical outcomes"
    Fernandez-Llimos, F
    Faus, MJ
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (22) : 2348 - +
  • [6] Assessment of drug-related problems in clinical nutrition patients
    Cerulli, J
    Malone, M
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (04) : 218 - 221
  • [7] An ABC of drug-related problems
    Meyboom, RHB
    Lindquist, M
    Egberts, ACG
    [J]. DRUG SAFETY, 2000, 22 (06) : 415 - 423
  • [8] An ABC of Drug-Related Problems
    Ronald H.B. Meyboom
    Marie Lindquist
    Antoine C.G. Egberts
    [J]. Drug Safety, 2000, 22 : 415 - 423
  • [9] Consequences of drug-related problems
    Thomsen, L. A.
    Frokjaer, B.
    Herborg, H. H.
    Rossing, C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (03) : 503 - 503
  • [10] Management of epilepsy in Lebanon: Medication reviews and drug-related problems
    Mroueh, Lara
    Al-Hajje, Amal
    Salameh, Pascale
    Preux, Pierre-Marie
    Boumediene, Farid
    Ratsimbazafy, Voa
    Jost, Jeremy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (05) : 583 - 591
12345